Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Truth About Weight Loss Drugs
Analysis finds that after 2 years GLP-1 drugs for weight loss don’t justify their price
Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the medications.
Why more doctors are treating children and adolescents with weight loss drugs
Physicians are increasingly using weight loss drugs to treat obesity, diabetes and other chronic conditions in young patients. In the last three years, the number of people between the ages of 12 and 25 using drugs like Wegovy and Ozempic has surged nearly 600 percent.
The Truth About Weight Loss Drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Are you wondering whether you’re a candidate for one of the
Weight-Loss Surgeries Drop 25 Percent As Americans Opt For GLP-1 Medications
A study shows a 25.6 per cent decline in weight-loss surgeries as more Americans turn to GLP-1 medications like Wegovy and Zepbound. Despite their popularity, high costs and side effects may lead to treatment discontinuation.
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Weight-Loss Drugs May Help Alcohol and Opioid Addiction
Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
While prescriptions for GLP-1 meds more than doubled between 2022 and 2023 (a rise of 132.6%), rates of bariatric surgery declined by 25.6%, the team found. Will these trends last?
Women turn to weight loss drugs in menopause: What to know about the benefits and risks
Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, according to Shepherd. The average age for menopause, when your periods stop permanently, is 52, according to the U.S. Office on Women's Health. Menopause is reached after it has been a full year since your last period.
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity
A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023.
1d
on MSN
Bariatric surgeries drop sharply as people turn to Wegovy, Saxenda for weight loss
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
KSL
13h
Weight loss drugs didn't curb health costs within 2 years, data show
In this analysis, only one in four patients prescribed
Wegovy
or Ozempic for
weight
loss
were still taking the ...
Opinion
3d
on MSN
Opinion
Stop the games. Make NC healthier by expanding weight-loss drug coverage | Opinion
Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...
2d
Weight-loss jabs are not ‘to get a body beautiful picture for Instagram’, says Wes Streeting
Weight-loss jabs are not a quick fix for an “Instagram body”, the Health Secretary has warned. The medicines regulator has ...
McKnight's Long-Term Care News
1d
Ozempic, Wegovy may lower Alzheimer’s risk in people with diabetes
Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...
2d
Regulator warns about people using weight loss jabs for 'aesthetic' reasons
Doctors have been urged to look out for 'signs of misuse' among patients using weight loss drugs. | ITV National News ...
2d
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Novo Nordisk on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
United States
GLP-1
Ozempic
Food and Drug Administration
Novo Nordisk
Feedback